Phytochemicals from Brazilian Red Propolis: A Review of Their Anti-Inflammatory Potential
Plants · 24.09.2025 · 14 (19) · 2961
DOI: 10.3390/plants14192961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plants, online erschienen am 24.09.2025. Verfasst von Thaise Boeing und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Program, Universidade do Vale do Itajaí, Itajaí 88302-901, Santa Catarina, Brazil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development, Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
Brazilian red propolis (BRP) has emerged as a promising source of multifunctional phytochemicals with potent anti-inflammatory activity. This review provides a comprehensive analysis of the anti-inflammatory effects of BRP’s bioactive compounds, their molecular targets, and their mechanisms of action. Isolated compounds from BRP (such as formononetin, biochanin A, daidzein, calycosin, medicarpin, vestitol, and neovestitol) have demonstrated the ability to modulate critical pro-inflammatory signaling pathways, including NF-κB, TLR4, JAK/STAT, and PI3K/AKT, while concurrently activating antioxidant and cytoprotective responses via the Nrf2/HO-1 axis. These effects are further supported by the suppression of pro-inflammatory cytokines, regulation of immune cell infiltration and activation, inhibition of inflammasome components such as NLRP3, induction of autophagy, and polarization of macrophages and microglia from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype. Collectively, these findings reinforce the potential of BRP as a rich source of multifunctional phytochemicals with broad therapeutic relevance for chronic inflammation and related pathologies. Future research should address the identified knowledge gaps by employing rigorous in vitro and in vivo toxicity assessments, exploring structure–activity relationships, and leveraging advanced delivery systems to optimize bioavailability. Such methodological approaches will be essential for translating the promising biological activities of BRP compounds into clinically viable therapeutic agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Sciences Program, Universidade do Vale do Itajaí, Itajaí 88302-901, Santa Catarina, Brazil.
- Biological Sciences Course, Universidade do Vale do Itajaí, Itajaí 88302-901, Santa Catarina, Brazil.
ORCID-Profile: Thaise Boeing, Rodolfo Moresco, Priscila de Souza
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- National Council for Scientific and Technological Development
- Coordination for the Improvement of Higher Education Personnel
- Foundation for Research and Innovation Support of the State of Santa Catarina (FAPESC)
Zitieren
APA
Boeing, T., Moresco, R., & de Souza, P. (2025). Phytochemicals from Brazilian Red Propolis: A Review of Their Anti-Inflammatory Potential. Plants, 14(19), 2961. https://doi.org/10.3390/plants14192961
Vancouver
Boeing T, Moresco R, de Souza P. Phytochemicals from Brazilian Red Propolis: A Review of Their Anti-Inflammatory Potential. Plants. 2025;14(19):2961. doi:10.3390/plants14192961
BibTeX
@article{Boeing2025,
author = {Boeing, Thaise and Moresco, Rodolfo and de Souza, Priscila},
title = {Phytochemicals from Brazilian Red Propolis: A Review of Their Anti-Inflammatory Potential},
journal = {Plants},
year = {2025},
volume = {14},
number = {19},
pages = {2961},
doi = {10.3390/plants14192961}
}
EUVIMED